Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/67979

Registo completo
Campo DCValorIdioma
dc.contributor.authorOliveira, D. M. L.por
dc.contributor.authorRezende, P. S.por
dc.contributor.authorBarbosa, T. C.por
dc.contributor.authorNalone, L. A.por
dc.contributor.authorBani, C.por
dc.contributor.authorTavares, D. S.por
dc.contributor.authorSilva, C. F. dapor
dc.contributor.authorChaud, M. V.por
dc.contributor.authorPadilha, F.por
dc.contributor.authorCano, A.por
dc.contributor.authorAlbuquerque Júnior, R. L. C. depor
dc.contributor.authorSouto, Eliana B.por
dc.contributor.authorSeverino, P.por
dc.date.accessioned2020-11-02T17:37:10Z-
dc.date.available2020-11-02T17:37:10Z-
dc.date.issued2020-
dc.identifier.citationOliveira, D. M. L.; Rezende, P. S.; Barbosa, T. C.; Nalone, L. A.; Bani, C.; Tavares, D. S.; Silva, C. F. da; Chaud, M. V.; Padilha, F.; Cano, A.; Albuquerque Júnior, R. L. C. de; Souto, Eliana; Severino, P., Double membrane based on lidocaine-coated polymyxin-alginate nanoparticles for wound healing: in vitro characterization and in vivo tissue repair. International Journal of Pharmaceutics, 591(120001), 2020por
dc.identifier.issn0378-5173por
dc.identifier.urihttps://hdl.handle.net/1822/67979-
dc.description.abstractThe aim of this study was to develop and characterize a double layer biomembrane for dual drug delivery to be used for the treatment of wounds. The membrane was composed of chitosan, hydroxypropyl methylcellulose and lidocaine chloride (anesthetic drug) in the first layer, and of sodium alginate-polymyxin B sulphate (antibiotic) nanoparticles as the second layer. A product with excellent thickness (0.01-0.02 mm), adequate mechanical properties with respect to elasticity, stiffness, tension, and compatible pH for lesion application has been successfully obtained. The incorporation of the drugs was confirmed analysing the membrane cross-sections by scanning electron microscopy. A strong interaction between the drugs and the functional groups of respective polymers was confirmed by Fourier-Transform Infrared Spectroscopy, thermal analysis and X-ray diffraction. Microbiological assays showed a high antimicrobial activity when polymyxin B was present to act against the Staphylococcus aureus and Pseudomonas aeruginosa strains. Low cytotoxicity observed in a cell viability colorimetric assay and SEM analysis suggest biocompatibility between the developed biomembrane and the cell culture. The in vivo assay allowed visualizing the healing potential by calculating the wound retraction index and by histological analysis. Our results confirm the effectiveness of the developed innovative biomaterial for tissue repair and regeneration in an animal model.por
dc.description.sponsorshipThe authors acknowledge the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/Brazil), Fundação de Amparo a Pesquisa do Estado de Sergipe (FAPITEC, MS/CNPq/FAPITEC/SE/SES N◦06/2018) e do Conselho Nacional de Pesquisas (CNPq, Apoio a Projetos de Pesquisa/MCTI/CNPQ/Universal 14/2014) for supporting funds. EBS acknowledges the Portuguese Science and Technology Foundation (FCT) for the funded projects M-ERA-NET/0004/2015 (PAIRED) and UIDB/04469/2020 (strategic fund) financed from national funds, and co-financed Education (FCT/MEC) from national funds and FEDER, under the Partnership Agreement PT2020.por
dc.language.isoengpor
dc.publisherElsevier 1por
dc.relationUIDB/04469/2020por
dc.rightsopenAccesspor
dc.subjectdouble membranepor
dc.subjectpolymyxin B sulphatepor
dc.subjectlidocaine hydrochloridepor
dc.subjectsolid lipid nanoparticlespor
dc.subjectburst releasepor
dc.subjectcontrolled releasepor
dc.titleDouble membrane based on lidocaine-coated polymyxin-alginate nanoparticles for wound healing: in vitro characterization and in vivo tissue repairpor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://www.elsevier.com/locate/issn/03785173por
dc.commentsCEB53951por
oaire.citationVolume591por
dc.date.updated2020-10-31T11:45:15Z-
dc.identifier.doi10.1016/j.ijpharm.2020.120001por
dc.identifier.pmid33141086por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersion-
dc.subject.wosScience & Technologypor
sdum.journalInternational Journal of Pharmaceuticspor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_53951_1.pdf15,22 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID